Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | -.--% | -.--% |
Valuation
Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Capitalization 1 | 0.8052 | 1.235 | 8.725 | 0.9348 | 59.42 | 19.57 |
Enterprise Value (EV) 1 | 0.8043 | 1.279 | 8.808 | 1.159 | 59.65 | 19.85 |
P/E ratio | - | - | -2.04 x | -4.47 x | -205 x | -69.1 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 132 x | 229 x | - | - | - | - |
EV / Revenue | 131 x | 237 x | - | - | - | - |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | 75.5 x | - | - | - | - | - |
FCF Yield | 1.32% | - | - | - | - | - |
Price to Book | - | - | -28.2 x | -2.81 x | -150 x | -14.6 x |
Nbr of stocks (in thousands) | 3.22 | 2.99 | 156 | 156 | 59,424 | 20,604 |
Reference price 2 | 250.0 | 412.6 | 56.00 | 6.000 | 1.000 | 0.9500 |
Announcement Date | 9/26/16 | 6/28/18 | 10/24/18 | 12/11/19 | 10/19/20 | 10/14/21 |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Net sales 1 | 0.006118 | 0.005386 | - | - | - | - |
EBITDA | - | - | - | - | - | - |
EBIT 1 | -0.0384 | -0.0877 | -0.1189 | -0.0565 | -0.0331 | -0.0454 |
Operating Margin | -627.02% | -1,628.93% | - | - | - | - |
Earnings before Tax (EBT) 1 | -0.0384 | -0.3411 | -1.741 | -0.2089 | -0.122 | -0.1065 |
Net income 1 | -0.0384 | -0.3233 | -1.741 | -0.2089 | -0.122 | -0.1065 |
Net margin | -627.02% | -6,002.84% | - | - | - | - |
EPS | - | - | -27.46 | -1.341 | -0.004882 | -0.0137 |
Free Cash Flow 1 | 0.0107 | - | - | - | - | - |
FCF margin | 174.19% | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 9/26/16 | 6/28/18 | 10/24/18 | 12/11/19 | 10/19/20 | 10/14/21 |
Balance Sheet Analysis
Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 0.04 | 0.08 | 0.22 | 0.23 | 0.28 |
Net Cash position 1 | 0 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 0.01 | - | - | - | - | - |
ROE (net income / shareholders' equity) | 28.7% | 180% | 646% | 65.1% | 33.5% | 23.7% |
ROA (Net income/ Total Assets) | -3,090% | - | - | - | - | - |
Assets 1 | 0.001242 | - | - | - | - | - |
Book Value Per Share | - | - | -1.990 | -2.130 | -0.0100 | -0.0600 |
Cash Flow per Share | - | - | - | - | - | - |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 9/26/16 | 6/28/18 | 10/24/18 | 12/11/19 | 10/19/20 | 10/14/21 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 7 | |
+172.40% | 6.72B | |
+7.92% | 1B | |
+2.14% | 982M | |
+41.91% | 872M | |
+18.89% | 783M | |
+1.72% | 664M | |
+35.80% | 644M | |
-.--% | 600M | |
+3.61% | 507M |
- Stock Market
- Equities
- BIIO Stock
- Financials Bionovate Technologies Corp